Images List Premium Download Classic

Cytokine

Cytokine-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Assay panels
Meso Scale Technologies, Llc.
February 15, 2018 - N°20180045720

Described herein are kits and components thereof used for a multiplexed analysis of a set of cytokines.
Car-expressing cells against multiple tumor antigens and uses thereof
The Trustees Of The University Of Pennsylvania
February 15, 2018 - N°20180044424

The invention provides compositions and methods for treating cancer by using immune effector cells (e. G., t cells, nk cells) engineered to conditionally express an agent which enhances the immune effector response of an immune effector cell that expresses a chimeric antigen receptor (car). The conditional agents described herein include agents that target a cancer associated antigen, e. G., a ...
Compositions and methods for preventing and treating rhinovirus infections
University Of Virginia Patent Foundation
February 15, 2018 - N°20180043006

An analysis of human cd4+ t-cell epitopes of rv capsid proteins with cross-reactive potential was performed, peptide epitopes of rv-a16 capsid proteins vp1 and vp2 were identified, rv-specific cd4+ t cells were phenotyped for surface markers and cytokine profiles using flow cytometry, and it was found that, among non-infected subjects, circulating rv-a16-specific cd4+ t cells detected at the highest ...
Cytokine Patent Pack
Download 175+ patent application PDFs
Cytokine Patent Applications
Download 175+ Cytokine-related PDFs
For professional research & prior art discovery
inventor
  • 175+ full patent PDF documents of Cytokine-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method for treating hiv
Enzo Therapeutics, Inc.
February 08, 2018 - N°20180036326

The present invention provides novel processes for regulating immune responses in mammalian subjects, e. G., humans, afflicted with diseases such as cancers, infections, e. G., viral infections, bacterial infections, or immune dysfunctions, especially auto-immune disorders, e. G., diabetes, crohn's disease, rheumatoid arthritis, arteriosclerosis and ulcerative colitis. More particularly, this invention relates to generating elevated levels of an intermediary metabolite, e. ...
Icos binding proteins
Centre National De La Recherche Scientifique (cnrs)
February 01, 2018 - N°20180030136

The present invention relates to an icos binding protein or antigen binding portion thereof that is an agonist to human icos and does not induce complement, adcc, or cdc when placed in contact with a t cell in vivo and methods of treating cancer, infectious disease and/or sepsis with said icos binding protein or antigen binding portion thereof. Further ...
Method for treating a tumor with bifunctional agents that bind to tumor carbohydrate antigens
February 01, 2018 - N°20180030123

A method for treating a tumor with at least two bifunctional agents. The bifunctional agents each include a binding domain that specifically binds to stage-specific embryonic antigen 4 (ssea4) or an ssea4 analog, and an effector domain selected from a cytokine, a cytotoxic agent, an immunoglobulin fc domain, anti-cd3, and anti-cd16.
Cytokine Patent Pack
Download 175+ patent application PDFs
Cytokine Patent Applications
Download 175+ Cytokine-related PDFs
For professional research & prior art discovery
inventor
  • 175+ full patent PDF documents of Cytokine-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods and apparatus for multi-vessel renal neuromodulation
Medtronic Ardian Luxembourg S.a.r.l.
January 25, 2018 - N°20180021574

Methods and apparatus are provided for multi-vessel neuromodulation, e. G., via a pulsed electric field. Such multi-vessel neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, the multi-vessel neuromodulation is applied to neural ...
Composition and method for improving sleep duration and quality
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
January 25, 2018 - N°20180021411

An intervention for sleep disorders comprises: collagen, a gelatin peptide, or the amino acid glycine; l-theanine; lactucopicrin, deoxylactucopicrin, or another lactucopicrin derivative; hyaluronic acid; epigallocatechin gallate; and quinic acid. The intervention helps regulate pro-inflammatory biomarkers that are often associated with insomnia development and progression. These biomarkers include cytokines and enzymes associated with tryptophan degradation. Inhibition of these enzymes and cytokines ...
Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses ...
Igf Oncology, Llc
January 25, 2018 - N°20180021408

Fusion proteins comprising cytokines, particularly insulin-like growth factor-1 (igf-1) and variants thereof, epidermal growth factor (egf), and other ligands to the egf receptor, are provided. The fusion proteins further comprise seq id no:1 or other segments having lysine, glutamic acid, or aspartic acid residues. Uses for the fusion proteins are also provided.
Nutritional approach to the control of anemia, diabetes and other diseases or conditions and prevention ...
Entia Biosciences, Inc.
January 25, 2018 - N°20180021405

Nutritional products, compositions, pharmaceutical preparations and methods of use are disclosed for the prevention, suppression and treatment of anemia and/or diabetes and its various associated comorbidities. Uses of ergothioneine to neutralize free radicals and/or cytokines, reduce oxidative stress, prevent inflammation, stimulate red blood cell production with increased levels of hemoglobin, and/or stabilize iron in its normal 2+ charge ...
Compositions and methods for treatment of intracellular damage and bacterial infection
Bioincept, Llc
January 25, 2018 - N°20180021401

Pre-implantation factor (pif) may be used to treat intracellular damage. Aspects of the invention are directed to a method of treating intracellular damage comprising administering pif to a subject in need thereof. Some aspects may be directed to methods of increasing cytokine secretion in response to intracellular damage comprising administering pif to a subject in need thereof. The intracellular damage ...
Treatment or prevention of surgery-induced cachexia and/or expression of myeloid-derived suppressor cells and pro-inflammatory ...
Nestec S.a.
January 25, 2018 - N°20180021279

A specialized immunonutrition supplement can be administered to a surgical patient to reduce post-operative complications by restraining the expansion of myeloid-derived suppressor cells. The supplement includes one or more of l-arginine, omega-3 fatty acids, vitamin a, and dietary nucleotides, preferably all four of these compounds. The supplement is administered to the patient at least once per day for a time ...
Multiplexed assay kit to evaluate the efficacy of treatment for inflammatory bowel disease
Meso Scale Technologies, Llc.
January 18, 2018 - N°20180017578

Disclosed are methods for conducting diagnostic tests for the detection of the inflammatory bowel diseases, such as crohn's disease and ulcerative colitis. Also described are methods for monitoring a patient by administering tests of the present invention. Also described are methods for monitoring patient's treatment by administering tests of the present invention. Also described are methods for evaluating the effectiveness ...
Cytokine Patent Pack
Download 175+ patent application PDFs
Cytokine Patent Applications
Download 175+ Cytokine-related PDFs
For professional research & prior art discovery
inventor
  • 175+ full patent PDF documents of Cytokine-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Superkines and synthekines: repurposed cytokines with new and enhanced signaling activities
The Board Of Trustees Of The Leland Stanford Junior University
January 18, 2018 - N°20180016316

Disclosed herein are il-4 cytokine compositions with enhanced biological activity having increased selectivity for il-4 cytokine receptors, and methods for their use. These compositions encompass interleukin-4 (il-4) muteins. The disclosed methods encompass administering an il-4 to treat neoplastic diseases, autoimmune diseases, infectious diseases or for expanding a hematopoietic cell population.
Use of prg4 as an anti-inflammatory agent
Rhode Island Hospital, A Lifespan Partner
January 18, 2018 - N°20180015141

Disclosed herein are methods of using prg4 glycoprotein, also known as lubricin, to reduce, inhibit, or down-regulate pro-inflammatory pathways in patients at risk of or suffering from an inflammatory response or allergy symptom through cd44 antagonization, regulating pro-inflammatory cytokine production, inhibiting nf-κb translocation and/or facilitating removal of inflammation-inducing cellular or matrix debris or allergens.
Markers of alzheimers disease
Immunoclin Ltd.
January 11, 2018 - N°20180010182

The use of markers that participate in inflammatory processes and are associated cytokines in the diagnosis, treatment or prophylaxis of diseases is disclosed. Specifically, cytokines are used to diagnose or treat non-neoplastic or non-leukaemic diseases such as autoimmune diseases or neurodegenerative disorders by the process of taking a dna bearing sample from a subject animal and analysing the sample to ...
Thin film cell encapsulation devices
The Regents Of The University Of California
January 11, 2018 - N°20180010089

Thin film devices, e. G., multilayer thin film devices, that encapsulate cells for transplantation into a subject are provided. Also provided are methods of using and methods of preparing the subject devices. The thin film devices include a first porous polymer layer and a second porous polymer layer that define a lumen therebetween and encapsulate a population of cells within ...
Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal
Zimmer Trabecular Metal Technology, Inc.
January 11, 2018 - N°20180008747

Adult autologous stem cells cultured on a porous, three-dimensional tissue scaffold-implant for bone regeneration by the use of a hyaluronan and/or dexamethasone to accelerate bone healing alone or in combination with recombinant growth factors or transfected osteogenic genes. The scaffold-implant may be machined into a custom-shaped three-dimensional cell culture system for support of cell growth, reservoir for peptides, recombinant ...
Sulphated hyaluronic acids as regulator agents of the cytokine activity
Fidia Farmaceutici S.p.a.
January 11, 2018 - N°20180008628

The object of the present invention relates to the new and surprising use of sulfated hyaluronic acid (has) as regulator agent of the cytokine activity (pro- and antiinflammatory) and consequently the use of has for the preparation of a new medicine for the prevention and treatment of pathologies associated with the activation and/or deficiency of cytokines of a pro- ...
Method of treating scoliosis using a biological implant
January 11, 2018 - N°20180008314

The present invention is a bone growth stimulating and promoting cytokine type biological implant preferably comprising pth coated with a controlled release biodegradable coating that is implanted preferably in the concave side of a scoliotically curved spine in combination with a bone growth inhibiting type biological implant preferably comprising methotrexate or like anti-metabolite coated with a controlled release biodegradable coating ...
Inflammatory disease diagnosis and methods of treatment using lipopolysaccharide-responsive beige-like anchor
University Of South Florida
January 04, 2018 - N°20180002413

Anti-cytokine therapy has revolutionized immunological disease treatment, but is not always effective and subject to treatment resistance as the cytokine cascade is highly redundant and multiple cytokines are involved in inflammation. Targeting a critical common regulator of inflammatory effectors is desirable. Lipopolysaccharide (lps)-responsive beige-like anchor (lrba) is a master regulator of multiple genes important for inflammation. Subcellular localization shows ...
Loading